Divergent Roles of Nitric Oxide and Rho Kinase in Vasomotor Regulation of Human Retinal Arterioles

被引:58
作者
Hein, Travis W. [1 ,2 ]
Rosa, Robert H., Jr. [1 ,2 ]
Yuan, Zhaoxu [1 ,2 ]
Roberts, Elizabeth [1 ,2 ]
Kuo, Lih [1 ,2 ,3 ]
机构
[1] Scott & White Eye Inst, Dept Ophthalmol, Temple, TX 76504 USA
[2] Scott & White Eye Inst, Dept Surg, Temple, TX 76504 USA
[3] Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, Coll Med, Temple, TX USA
基金
美国国家卫生研究院;
关键词
VASCULAR SMOOTH-MUSCLE; OCULAR BLOOD-FLOW; K-ATP CHANNELS; DIABETIC-RETINOPATHY; ENDOTHELIAL FUNCTION; ENDOTHELIN-1-INDUCED CONTRACTION; FLICKER STIMULATION; ADENOSINE; DILATION; ARTERY;
D O I
10.1167/iovs.09-4391
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Although the arteriolar segment contributes to flow regulation, there is sparse information at the single microvessel level on how vasomotor function is regulated in the human retina. The authors have previously reported vasoreactivity and its underlying mechanisms in isolated porcine retinal arterioles. Herein, they studied human retinal arterioles for comparison. METHODS. Retinal tissues were obtained from seven patients undergoing enucleation. Human and porcine retinal arterioles were isolated and pressurized to 55 cm H(2)O luminal pressure for vasoreactivity study using videomicroscopic techniques. RESULTS. Isolated human and porcine retinal arterioles developed myogenic tone and dilated dose dependently to bradykinin, adenosine, and sodium nitroprusside. Stepwise increases in luminal flow produced graded dilation with approximately 60% dilation at the highest flow tested. Nitric oxide (NO) synthase inhibitor L-NAME nearly abolished dilations to bradykinin and flow and attenuated the adenosine-induced dilation without altering the response to nitroprusside. Endothelin-1 caused dose-dependent constriction. Rho kinase (ROCK) inhibitor H-1152 blocked both myogenic tone and endothelin-1-induced constriction. Responses of retinal arterioles to all agonists and increased flow were similar between pigs and humans. CONCLUSIONS. Isolated human retinal arterioles dilate to bradykinin and increased flow in an NO-dependent manner. NO contributes, in part, to adenosine-induced vasodilation. Conversely, ROCK activation mediates myogenic tone and endothelin-1-induced vasoconstriction. Similarities in these vasoactive responses and the underlying mechanisms between human and porcine retinal arterioles support the latter as a viable experimental model of the human retinal microcirculation. (Invest Ophthalmol Vis Sci. 2010; 51: 1583-1590) DOI: 10.1167/iovs.09-4391
引用
收藏
页码:1583 / 1590
页数:8
相关论文
共 59 条
[51]  
RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124
[52]  
Roldan-Pallares M, 2005, MOL VIS, V11, P461
[53]   DILATOR RESPONSE OF RAT MESENTERIC ARCADING ARTERIOLES TO INCREASED BLOOD-FLOW VELOCITY [J].
SMIESKO, V ;
LANG, DJ ;
JOHNSON, PC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (06) :H1958-H1965
[54]   Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II [J].
Somlyo, AP ;
Somlyo, AV .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 522 (02) :177-185
[55]   Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy [J].
Toda, Noboru ;
Nakanishi-Toda, Megumi .
PROGRESS IN RETINAL AND EYE RESEARCH, 2007, 26 (03) :205-238
[56]   The endothelium and inflammation [J].
Trepels, Thomas ;
Zeiher, Andreas. M. ;
Fichtlscherer, Stephan .
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2006, 13 (06) :423-429
[57]   A NOVEL POTENT VASOCONSTRICTOR PEPTIDE PRODUCED BY VASCULAR ENDOTHELIAL-CELLS [J].
YANAGISAWA, M ;
KURIHARA, H ;
KIMURA, S ;
TOMOBE, Y ;
KOBAYASHI, M ;
MITSUI, Y ;
YAZAKI, Y ;
GOTO, K ;
MASAKI, T .
NATURE, 1988, 332 (6163) :411-415
[58]   Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles [J].
Yu, DY ;
Su, EN ;
Cringle, SJ ;
Alder, VA ;
Yu, PK ;
Desantis, L .
EXPERIMENTAL EYE RESEARCH, 1998, 67 (01) :73-81
[59]   SECRETION OF ENDOTHELIN-1 AND ENDOTHELIN-3 BY HUMAN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
YU, JCM ;
DAVENPORT, AP .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (02) :551-557